MedPath

NDT Effectiveness Study

Not Applicable
Completed
Conditions
Neuromuscular Diseases
Cerebral Palsy
Neurodevelopment Treatment
Registration Number
NCT05070910
Lead Sponsor
MultiCare Health System Research Institute
Brief Summary

The purpose of this study is to determine whether there is a functional change in children with Cerebral Palsy (CP) and other neuromuscular disorders participating in Neurodevelopmental Treatment (NDT) intervention using the contemporary practice model (CPM).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • The children will be aged 2 to 15 years with a diagnosis of CP, hypotonia, global developmental delay and/ or neuromuscular disorders not otherwise specified.
  • Children must also be willing to receive physical guidance for movement and clearly attempt to respond to simple instructions on request.
  • Children and their families are available and willing to attend the practicum portion of the course for both blocks.
Exclusion Criteria
  • Parent/Guardian unable to complete the 4 required interview sessions.
  • Unable to commit to attending 75% of practicum sessions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Significant increase in functional outcomes in COPM scoresSignificant change after an 8 week NDT-CPM treatment occurring from November 2, 2021 to completion on March 12, 2022

Change functional outcomes in COPM scores after NDT-CPM treatment.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Good Samaritan Hospital

🇺🇸

Puyallup, Washington, United States

Good Samaritan Hospital
🇺🇸Puyallup, Washington, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.